570 related articles for article (PubMed ID: 19428842)
1. Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.
Hedhli D; Dimier-Poisson I; Judge JW; Rosenberg B; Mévélec MN
Vaccine; 2009 Apr; 27(16):2274-81. PubMed ID: 19428842
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
Xue M; He S; Cui Y; Yao Y; Wang H
Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
[TBL] [Abstract][Full Text] [Related]
4. [Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii].
Yin GR; Meng XL; Ma GY; Ma XM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):290-4. PubMed ID: 18038798
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.
Igarashi M; Kano F; Tamekuni K; Machado RZ; Navarro IT; Vidotto O; Vidotto MC; Garcia JL
Exp Parasitol; 2008 Mar; 118(3):386-92. PubMed ID: 18154953
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.
Stanley AC; Buxton D; Innes EA; Huntley JF
Vaccine; 2004 Sep; 22(29-30):3929-41. PubMed ID: 15364441
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice.
Chen G; Chen H; Guo H; Zheng H
Chin Med J (Engl); 2002 Oct; 115(10):1448-52. PubMed ID: 12490084
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
Golkar M; Shokrgozar MA; Rafati S; Musset K; Assmar M; Sadaie R; Cesbron-Delauw MF; Mercier C
Vaccine; 2007 May; 25(21):4301-11. PubMed ID: 17418457
[TBL] [Abstract][Full Text] [Related]
11. Montanide IMS 1313 N VG PR nanoparticle adjuvant enhances antigen-specific immune responses to profilin following mucosal vaccination against Eimeria acervulina.
Jang SI; Lillehoj HS; Lee SH; Lee KW; Lillehoj EP; Bertrand F; Dupuis L; Deville S
Vet Parasitol; 2011 Dec; 182(2-4):163-70. PubMed ID: 21700391
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts.
Parmley S; Slifer T; Araujo F
J Infect Dis; 2002 Feb; 185 Suppl 1():S90-5. PubMed ID: 11865445
[TBL] [Abstract][Full Text] [Related]
13. The antigen-specific response to Toxoplasma gondii profilin, a TLR11/12 ligand, depends on its intrinsic adjuvant properties.
Hedhli D; Moiré N; Akbar H; Laurent F; Héraut B; Dimier-Poisson I; Mévélec MN
Med Microbiol Immunol; 2016 Aug; 205(4):345-52. PubMed ID: 26935827
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
Yang X; Huang S; Chen J; Song N; Wang L; Zhang Z; Deng G; Zheng H; Zhu XQ; Lu F
Vaccine; 2010 Jan; 28(3):737-43. PubMed ID: 19887128
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
[TBL] [Abstract][Full Text] [Related]
16. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
[TBL] [Abstract][Full Text] [Related]
17. Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA.
Dimier-Poisson I; Aline F; Bout D; Mévélec MN
Vaccine; 2006 Mar; 24(10):1705-9. PubMed ID: 16256251
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
19. Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection.
Jang SI; Lillehoj HS; Lee SH; Lee KW; Park MS; Bauchan GR; Lillehoj EP; Bertrand F; Dupuis L; Deville S
Vet Parasitol; 2010 Sep; 172(3-4):221-8. PubMed ID: 20541870
[TBL] [Abstract][Full Text] [Related]
20. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
Khan IA; Casciotti L
J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]